How Welton ESG Advantage Helped Investors Navigate Q1 2022
The first quarter of 2022 threw a daunting number of curves at investors. The confluence of higher inflation brought about, in part, by the lengthy pandemic, the Russian war with Ukraine and the January tech meltdown producing a sharp spike in market volatility....
My Career in ESG Investing is Rooted in My Upbringing
“It is not in the stars to hold our destiny but in ourselves.” ― William Shakespeare My ESG journey began with Welton about two years ago, but sustainability is deeply rooted in me by virtue of my unique upbringing. My father is a true visionary, and I...
Commodity Surge Is Just the Latest Event in a Rollercoaster 3-Year Macro Ride
Not long ago commodity prices were falling, now they’re surging. Today, I see green across every quote in every commodity sector from my front-row seat managing the trade flow for $7B in Macro positions. At the start of the pandemic-induced global shutdown in 2020, we...
The Big Picture: Debt, growth and rates’ abnormal relationships creating abnormal conditions (Part II)
B. G., Opalesque Geneva In this interview, Dr. Patrick Welton, founder and CIO of Welton Investment Partners, an alternative asset manager, offers his observations on the major macro themes expected to affect the markets in 2022. In this final part, he talks about ESG...
The Big Picture: Watch out for continuing supply-chain issues and moving commodity prices this year (Part I)
B. G., Opalesque Geneva In this interview, Dr. Patrick Welton, founder and CIO of Welton Investment Partners, an alternative asset manager, offers his observations on the major macro themes expected to affect the markets in 2022. Welton Investment Partners specialises...
Nile Capital Group Completes Strategic Investment in Welton Investment Partners
New York, NY – Jan. 12, 2022 – Welton Investment Partners (“Welton” or the “Company”), an over $1B Global Macro and ESG investment manager, today announced that Nile Capital Group Holdings, LLC (“Nile”) has completed a strategic minority investment in the Company....
What Do Medical and Financial Research Have in Common? (Unfortunately). And, What Can You Do to Protect Yourself?
Regrettably, only a fraction of published medical research is reproducible by other investigators. This is no surprise to those of us who contribute or follow medical advancements. Hundreds of reviews have documented tens of thousands of examples. From cancer biology...
Seeking Protection from Inflationary Spikes? Some thoughts.
How might an investor protect themselves from the recent inflationary spike? How might they rationally act as the news is worsening? From a macroeconomic investor perspective, I offer caution in reacting to the news. The crescendo of news transmits multiple signals....